Suppr超能文献

一种 RNA 适体对 AMPA 受体开放通道构象的强效和选择性抑制。

Potent and selective inhibition of the open-channel conformation of AMPA receptors by an RNA aptamer.

机构信息

Department of Chemistry and Center for Neuroscience Research, University at Albany, State University of New York, Albany, New York 12222, USA.

出版信息

Biochemistry. 2010 Jul 13;49(27):5790-8. doi: 10.1021/bi100690k.

Abstract

Inhibitors of AMPA receptors are useful as biochemical probes for structure-function studies and as drug candidates for a number of neurological disorders and diseases. Here we report the identification of an RNA inhibitor or aptamer by an in vitro evolution approach. Using a laser-pulse photolysis technique, we further characterized the mechanism of inhibition of this aptamer on the AMPA receptor channel-opening rate process in the microsecond-to-millisecond time domain. Our results show that the aptamer we isolated is a noncompetitive inhibitor that selectively inhibits the open-channel conformation of AMPA receptors with nanomolar affinity. The potency and the selectivity of this noncompetitive aptamer rival those of small molecule inhibitors. Our results therefore demonstrate the utility of this approach in developing water-soluble, highly potent, and conformation-selective noncompetitive inhibitors of AMPA receptors.

摘要

AMPA 受体抑制剂可用作生化探针,用于研究结构-功能关系,也可用作多种神经紊乱和疾病的药物候选物。在此,我们报告了一种通过体外进化方法鉴定的 RNA 抑制剂或适体。我们进一步使用激光脉冲光解技术,在微秒到毫秒的时间域内对这种适体在 AMPA 受体通道开启速率过程中的抑制机制进行了表征。我们的结果表明,我们分离出的适体是一种非竞争性抑制剂,它以纳摩尔亲和力选择性地抑制 AMPA 受体的开放通道构象。这种非竞争性适体的效力和选择性可与小分子抑制剂相媲美。因此,我们的结果证明了这种方法在开发水溶性、高效能和构象选择性的 AMPA 受体非竞争性抑制剂方面的实用性。

相似文献

3
9
Developing RNA aptamers for potential treatment of neurological diseases.开发 RNA 适体用于潜在的神经疾病治疗。
Future Med Chem. 2019 Mar;11(6):551-565. doi: 10.4155/fmc-2018-0364. Epub 2019 Mar 26.

引用本文的文献

4
RNA aptamers for AMPA receptors.AMPA 受体的 RNA 适体。
Neuropharmacology. 2021 Nov 1;199:108761. doi: 10.1016/j.neuropharm.2021.108761. Epub 2021 Sep 9.
5
A kainate receptor-selective RNA aptamer.一种选择性作用于红藻氨酸受体的 RNA 适体。
J Biol Chem. 2020 May 8;295(19):6280-6288. doi: 10.1074/jbc.RA119.011649. Epub 2020 Mar 11.
7
Developing RNA aptamers for potential treatment of neurological diseases.开发 RNA 适体用于潜在的神经疾病治疗。
Future Med Chem. 2019 Mar;11(6):551-565. doi: 10.4155/fmc-2018-0364. Epub 2019 Mar 26.
9
RNA based antagonist of NMDA receptors.NMDA 受体的 RNA 基拮抗剂。
ACS Chem Neurosci. 2014 Jul 16;5(7):559-67. doi: 10.1021/cn500041k. Epub 2014 Apr 16.

本文引用的文献

2
Small-molecule activators of a proenzyme.一种酶原的小分子激活剂。
Science. 2009 Nov 6;326(5954):853-8. doi: 10.1126/science.1177585.
7

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验